Public Engagement

See our upcoming events


Jenner Institute




Africa-Europe partnership launched to develop new AIDS vaccine

Posted 15/02/2017

A new partnership has been formed between European and African researchers to develop an AIDS vaccine that can be used to prevent infection with different strains of HIV worldwide. Led by Professor Tomáš Hanke at the Jenner Institute, the Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT) will evaluate a new vaccine that triggers the body to produce specialised immune cells called T-cells, which will be trialled at four sites in Kenya, Uganda and Zambia.

International Day of Women in Science

Posted 10/02/2017

February 11th 2017 is International Day of Women in Science. Watch women scientists, including Jenner Investigators Prof Helen McShane and Prof Ellie Barnes, share their stories and speak about their career and life experiences, both inside and outside of the lab, including career pathways, funding challenges, work and life balance, mentorship, and career progression.

News Archive

Recent Publications

Evaluation of PvCelTOS as a pre-erythrocytic P. vivax vaccine. Clin Vaccine Immunol. Article

Astrocytes Resist HIV-1 Fusion but Engulf Infected Macrophage Material. Cell Rep, 18 (6), pp. 1473-1483. Article

Clinical Trials

Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.

If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.

Jenner Institute Podcasts

See all Jenner podcasts


Prof William R. Jacobs: Continuing to pursue Edward Jenner’s revenge: Sterilizing vaccines in chemotherapy for tuberculosis, 27/Feb/2017 12:00

Prof Reinout van Crevel: BCG induced trained immunity through epigenetic and metabolic reprogramming, 13/Mar/2017 11:00

All Seminars